Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCPK - Delayed Quote USD

Healixa Inc. (EMOR)

Compare
0.0400
0.0000
(0.00%)
At close: April 4 at 4:00:00 PM EDT
Loading Chart for EMOR
  • Previous Close 0.0000
  • Open 0.0360
  • Bid 0.0227 x --
  • Ask 0.0400 x --
  • Day's Range 0.0360 - 0.0400
  • 52 Week Range 0.0100 - 0.1500
  • Volume 85,000
  • Avg. Volume 12,927
  • Market Cap (intraday) 30.183M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Healixa Inc. operates as a technology company with assets in both healthtech and fintech. It offers tech solutions to enterprise partner channels across a range of industries, including employer benefits, travel, pharma, logistics, and other. Healixa Inc. also operates digital pharmacy marketplace. The company was formerly known as Emerald Organic Products Inc. and changed its name to Healixa Inc. in April 2021. The company was founded in 1977 and is based in Holbrook, New York.

healixa.com

--

Full Time Employees

--

Fiscal Year Ends

Recent News: EMOR

View More

Performance Overview: EMOR

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

EMOR
20.00%
S&P 500 (^GSPC)
13.73%

1-Year Return

EMOR
69.23%
S&P 500 (^GSPC)
1.42%

3-Year Return

EMOR
95.45%
S&P 500 (^GSPC)
10.72%

5-Year Return

EMOR
97.84%
S&P 500 (^GSPC)
103.89%

Compare To: EMOR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EMOR

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    30.18M

  • Enterprise Value

    30.18M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: EMOR

View More

Company Insights: EMOR

Research Reports: EMOR

View More

People Also Watch